NanoVation Therapeutics

Name	Position	Notes
Marco Ciufolini	Co-founder, Vice President, and Board Director (Canada)^[7]	Rice University, Claude Bernard University Lyon 1, University of British Columbia (UBC)
Pieter Cullis	Co-founder, Board Chair (Canada), and Board Director (United Kingdom)^[8]	Acuitas Therapeutics, UBC Department of Biochemistry & Molecular Biology, adMare BioInnovations, NanoMedicines Innovation Network (NMIN), Royal Society
Eric Jan	Co-founder and Board Director (Canada)^[7:1]	UBC Department of Biochemistry & Molecular Biology, Stanford University
Jayesh Kulkarni	Co-founder and Chief Scientific Officer^[2:3]^[7:2]	NanoMedicines Innovation Network (NMIN), Northern Lipids, BC Cancer Agency, University of British Columbia (UBC), Evonik, NanoMedicines Research Group
Dominik Witzigmann	Co-founder and CEO^[2:4]^[7:3]	NanoMedicines Innovation Network (NMIN), UCL School of Pharmacy, German Cancer Research Center, University of Basel Department of Pharmaceutical Sciences, Schwank Lab, University of British Columbia (UBC),^[9] Controlled Release Society (CRS), Biozentrum, Swiss Nanoscience Institute (NSI)^[10], European Society for Nanomedicine, Swiss Academy of Pharmaceutical Sciences, German Pharmaceutical Society (DPhG)
Marion Athané	Marketing & Events Manager^[11]	NanoMedicines Innovation Network (NMIN)^[12]
N. D. Prasad Atmuri	Associate Principal Scientist, Chemistry^[7:4]	University College London (UCL), University of Oxford, Hetero, Syngene, University of Montreal, University of British Columbia (UBC), StrongerBC, Mitacs^[13]
Martin Attwood	Senior Scientist, Biology^[7:5]	University College London (UCL), University of Oxford
Hanna Barriga	Consultant, Biophysics^[7:6]	Imperial College London (ICL), Karolinska Institute, Pfizer, Swedish Neutron Scattering Society (SNSS), KTH Royal Institute of Technology, New York Academy of Sciences^[14]
Marshall Beck	Communications and IT Consultant^[7:7]	NanoMedicines Innovation Network (NMIN), Centre for Research on Latin America and the Caribbean (CERLAC), CHILD Cohort Study, Centre for Refugee Studies (CRS), North American Congress on Latin America (NACLA)^[15]
Mayara Brandao	Senior Manager, People and Culture^[7:8]	VanHack, Community Living Society (CLS), Footprints Recruiting, Recife Center for Advanced Studies and Systems (CESAR), Grupo Contax^[16]
David Broemeling	Vice President of Operations^[7:9]	Boreal Genomics, Creative Destruction Lab (CDL), University of British Columbia (UBC), Natera^[17]
Frederick Campbell	Scientific Director, UK^[18]	University College London (UCL), Leiden University^[19]
Tony Cheung	Vice President of Finance^[7:10]	TIR Systems, Pacific Cellular, Lignol Energy Corporation, Evonik, Portable Electric, Transferra Nanosciences, Canadian Fishing Company (Canfisco), Scouts Canada^[20]
Christine DeMatteis	Lab Manager^[7:11]	Zymeworks, CARO Analytical Services^[21]
Arpan Desai	Managing Director, UK (March 2022-January 2024)^[2:5]^[22]	Visiongain, University of Melbourne, University of Nottingham, AstraZeneca, CamGene Therapeutics
Allison Enjetti	Senior Project Manager^[7:12]	AbCellera, U.S. President's Malaria Initiative, British Columbia Centre for Excellence in HIV/AIDS^[23]
Don Enns	Chief Business Officer^[7:13]	Molecular You, Evonik, Life Sciences British Columbia, Genome British Columbia^[24]
Julia Ayano Fernando	Scientist, Biology^[7:14]	HKU-Pasteur Research Pole, Swansea University
Bruno Fonseca	RNA Director^[7:15]	University of British Columbia (UBC), McGill University, AstraZeneca, Children's Hospital of Eastern Ontario (CHEO), Biologic and Radiopharmaceutical Drugs Directorate (BRDD), PrimerGen^[25]
Georgina Girt	Senior Scientist, Formulation (UK)^[7:16]	University of Oxford, Rosalind Franklin Institute (RFI), University of Leicester^[26]
Rupsa Gupta	Senior Associate Scientist, Formulation^[7:17]	Precision NanoSystems, NanoMat, Mitacs, Lower Mainland Bengali Cultural Society^[27]
Graham Hayes	Senior Scientist, Formulation^[7:18]	Infineum, University of Warwick^[28]
Kate Hollinshead	Senior Scientist, Translational Science^[29]	MedImmune, AstraZeneca, NYU Langone Health
Joshua Jeyakumar	Patent Associate^[7:19]	Intellectual Property Institute of Canada (IPIC), MaxVal Group, Effectual Services, Stellarix Consultancy Services^[30]
Japneet Kaur	Preclinical Research Technician^[7:20]	-
Daniel Kurek	Senior Scientist III, Formulation, Team Lead^[7:21]	University of Utah, BC Research, University of British Columbia (UBC), Evonik^[31]
Wendy Lamson	Chief Intellectual Property Officer^[7:22]	Intellectual Property Institute of Canada (IPIC), University of Ottawa, Lamson IP, Perley-Robertson, Hill & McDougall, Kirby Eades Gale Baker, Iogen, Celator Pharmaceuticals^[32]
Rafaela Marodin	Senior Research Associate, Formulation^[7:23]	Simon Fraser University (SFU), Renaissance BioScience, University of British Columbia (UBC), adMare BioInnovations^[33]
Michelle Martin	Human Resources Consultant^[7:24]	Forbes Medi-Tech, thriveHR, Aquinox Pharmaceuticals^[34]
Nigel McKenzie	Senior Manager, Operations^[7:25]	Natera, Celtic Reforestation, Quest University, BC Wildfire Service, Tübify Foods, SPUD, Smash + Tess, WERD Magazine, Momenta^[35]
Lívia Palmerston Mendes	Senior Scientist I, Formulation^[7:26]	Federal University of Goiás, Cifarma Científica Farmacêutica, Antimicrobial Discovery Center (ADC), Northeastern University, CureVac, Controlled Release Society, Abroaders^[36]
Ardalan Nabi	Scientist I, Chemistry^[7:27]	UBC Department of Chemistry, Soran University, University of Auckland^[37]
Ariane Nissenbaum	Senior Associate Scientist, RNA^[7:28]	Sunnybrook Health Sciences Centre, College of San Mateo (CSM), Atlantis, San Francisco State University, University of California, San Francisco (UCSF), Genentech, UCSF Benioff Children's Hospital at Mission Bay^[38]
Maryam Osooly	Preclinical Research Technician^[7:29]	BC Cancer Research Centre (BCCRC)
Grishma Pawar	Scientist II, Preclinical^[7:30]	Krembil Brain Institute (KBI), Maneesh Pharmaceuticals, Vivekanand Education Society College of Pharmacy, Sanofi, Northeastern University, Kalia Labs, University Health Network Postdoc Association (UHNPA), Indian Pharmaceutical Association (IPA)^[39]
Nicola Pett	Preclinical Research Associate^[7:31]	University of Calgary, University of Queensland
Atul Rangadurai	Scientist I, RNA^[7:32]	University of Toronto, SickKids, Indian Institute of Science (IISc)^[40]
Eleonore Rayner	Project Manager^[7:33]	University of British Columbia (UBC), Hammersmith Medicines Research (HMR), Kastrup Lab, Michael Smith Laboratories^[41]
Fariba Saadati	Senior Scientist III, Chemistry^[7:34]	University of British Columbia (UBC), Institute for Advanced Studies in Basic Sciences (IASBS)
Jessica Silva	Scientist, Preclinical Immunology^[7:35]	University of Tennessee at Martin, UBC Department of Microbiology and Immunology, Ronald McDonald House Charities, Phi Eta Sigma, Phi Kappa Phi^[42]
Molly Stevens	Scientific Advisor (Canada) and Board Member (UK)^[43]	Imperial College London (ICL), Karolinska Institute, Royal Society, Royal Academy of Engineering, National Academy of Engineering (NAE)
Anthony Tam	Scientist II, Preclinical Research^[7:36]	Vancouver Biotech Limited (VBL), British Columbia Institute of Technology (BCIT), University of British Columbia (UBC), Centre for Heart Lung Innovation (HLI), Mitacs^[44]
Huy Tran	Scientist II, Chemistry^[7:37]	University of Ottawa, Theravance Biopharma, Cytokinetics, Chemistry and Biomolecular Graduate Student Association (CBGSA), Queensway Carleton Hospital^[45]
Xinying Wang	RNA Scientist^[7:38]	-
John Williams	Company Secretary (UK)^[7:39]	Institute of Chartered Accountants in England and Wales (ICAEW)
Kathy Wong	Research Associate, RNA^[7:40]	British Columbia Centre for Disease Control (BCCDC)
Caroline Ye	Senior Scientist I, Formulation^[7:41]	Precision NanoSystems, Imperial College London (ICL), Kastrup Lab, Cat Therapy & Rescue Society^[46]

¶ NanoVation Therapeutics

¶ History

¶ Organization

¶ Personnel

¶ Patents

¶ External links